ORBIMED CAPITAL LLC

CIK 1157524 · last filed 2026-04-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$98.03M

Companies

7

Total Filings

15

Lifetime Open-Market Net

$39.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRLD Director 1,126,126 $4.49 $5.06M $65.00M 3 2026-04-23
SPRY Director 269,323 $9.76 $2.63M -$3.26M 1 2024-08-28
Kinnate Biopharma Inc. (KNTE) Delisted Director 1,368,339 $2.65 $3.63M $36.56M 3 2023-05-08
ARQT Director 3,534,537 $24.38 $86.17M $43.84M 3 2022-06-28
PMVP 10%+ Owner 109,500 $1.11 $121.5K -$41.06M 1 2022-03-31
Repare Therapeutics Inc. (RPTX) Delisted Director 3,221,637 $2.65 $8.54M -$1.85M 1 2021-08-30
ALEC Director 2,650,781 $1.53 $4.06M -$60.17M 3 2019-12-26

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-10-06 ARQT Buy (P) +1,488,000 $37.20M EDGAR
2020-02-04 ARQT Mixed +14,021,550 $28.50M EDGAR
2019-12-26 ALEC Sell (S) −1,558,155 -$30.63M EDGAR
2019-12-19 ALEC Sell (S) −2,862,300 -$53.01M EDGAR
2019-02-11 ALEC Mixed +39,282,087 $23.47M EDGAR
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.